Dorsey Wright & Associates’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Dorsey Wright & Associates’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-13,631	Closed	-$1.92M	–	304
2019 Q2	$1.92M	Buy	13,631 +1,477	+12%	+$204K	0.47%	91
2019 Q1	$1.83M	Buy	12,154 +1,567	+15%	+$226K	0.44%	100
2018 Q4	$1.31M	Sell	10,587 -1,967	-16%	-$269K	0.39%	91
2018 Q3	$1.99M	Buy	+12,554	New	+$1.9M	0.36%	91

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Dorsey Wright & Associates's FBT Position: Q3 2019 in Review

Dorsey Wright & Associates sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2019, closing a stake of 13,631 shares — an estimated $1.92M sold.

Dorsey Wright & Associates first reported a position in FBT in Q3 2018 and held it in 4 quarters. The position peaked at $1.99M in Q3 2018. 188 funds tracked by Wall St. Rank hold FBT as of Q3 2019.

Dorsey Wright & Associates reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2019 after selling out during the quarter.
Dorsey Wright & Associates sold 13,631 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2019, an estimated $1.92M.
Dorsey Wright & Associates first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2018 and held it in 4 quarters.
Dorsey Wright & Associates's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.99M in Q3 2018.
188 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2019.

Based on Dorsey Wright & Associates's 13F filing for Q3 2019, filed 31 Oct 2019.